Flibanserin Female Sex Hormone White Powder CAS NO 167933-07-5
Flibanserin/Addyi Datos de
Flibanserin CAS NO.:167933-07-5
Flibanserin Alias:3 – [2 – (4 – (4 – (3 metilo) fenil] piperazine – 1 – base] ethyl] – 1 h – benzimidazole – 2 – ketone
Flibanserin Molecular Formula:C20H21F3N4O
Flibanserin Molecular Weight:390.40
Flibanserin Purity: 99.5%
Flibanserin Melting point: 139-143° C
Flibanserin Packing: Stealth pack
Flibanserin Appearance: Polvo blanco
Flibanserin Grade:Grado farmacéutico
Flibanserin, sold under the trade name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD).The medication increases the number of satisfying sexual events per month by about one half to one over placebo from a starting point of about two to three.
Flibanserin is a novel, non-hormonal drug that has been studied in clinical trials for the treatment of HSDD in premenopausal and postmenopausal women. The application submitted to the FDA is for premenopausal women. Flibanserin is believed to work on key neurotransmitters, or chemicals, in the brain that affect sexual desire.
Flibanserin is being hailed as “Viagras for women.” The experimental drug – designed for post-menopausal women with low sex drives – has now won approval from an advisory panel for the Food and Drug Administration (FDA).
Flibanserin is an antidepressant that failed to help depression in clinical trials, but was noted to have improved sexual health outcomes. It’s not uncommon for a drug to be developed for one purpose, then approved for another. Sildenafill was originally developed to lower blood pressure, but failed those trials. The benefit of both of these drugs was discovered by accident. Sin embargo, flibanserin has now been studied for its effects on sexual health for nearly a decade.
Hormona del sexo del realce
|Citrato de sildenafil(Sildenafil)
|Mesilato de sildenafil